19-4101032-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PP3PP2

This summary comes from the ClinGen Evidence Repository: The c.692G>A (p.Arg231His) variant in MAP2K2 has been identified in a patient with clinical features consistent with cardiomyopathy (PS4 not met; Invitae internal data, GTR Lab ID 500031; ClinVar SCV000776886.1). The variant is located in the MAP2K2 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants and pathogenic missense variants are common (PP2; PMID:29493581). Computational prediction tools and conservation analysis suggest that the p.Arg231His variant may impact the protein (PP3). In summary, the clinical significance of the p.Arg231His variant is uncertain. RASopathy-specific ACMG/AMP criteria applied (PMID:29493581): PP2, PP3. LINK:https://erepo.genome.network/evrepo/ui/classification/CA9090854/MONDO:0021060/004

Frequency

Genomes: 𝑓 0.000026 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000035 ( 0 hom. )

Consequence

MAP2K2
NM_030662.4 missense

Scores

11
5
2

Clinical Significance

Uncertain significance reviewed by expert panel U:6

Conservation

PhyloP100: 7.86

Publications

11 publications found
Variant links:
Genes affected
MAP2K2 (HGNC:6842): (mitogen-activated protein kinase kinase 2) The protein encoded by this gene is a dual specificity protein kinase that belongs to the MAP kinase kinase family. This kinase is known to play a critical role in mitogen growth factor signal transduction. It phosphorylates and thus activates MAPK1/ERK2 and MAPK2/ERK3. The activation of this kinase itself is dependent on the Ser/Thr phosphorylation by MAP kinase kinase kinases. Mutations in this gene cause cardiofaciocutaneous syndrome (CFC syndrome), a disease characterized by heart defects, cognitive disability, and distinctive facial features similar to those found in Noonan syndrome. The inhibition or degradation of this kinase is also found to be involved in the pathogenesis of Yersinia and anthrax. A pseudogene, which is located on chromosome 7, has been identified for this gene. [provided by RefSeq, Jul 2008]
MAP2K2 Gene-Disease associations (from GenCC):
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • cardiofaciocutaneous syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • neurofibromatosis-Noonan syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Noonan syndrome
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PP2
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_030662.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP2K2
NM_030662.4
MANE Select
c.692G>Ap.Arg231His
missense
Exon 6 of 11NP_109587.1
MAP2K2
NM_001440688.1
c.692G>Ap.Arg231His
missense
Exon 6 of 9NP_001427617.1
MAP2K2
NM_001440689.1
c.122G>Ap.Arg41His
missense
Exon 4 of 9NP_001427618.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP2K2
ENST00000262948.10
TSL:1 MANE Select
c.692G>Ap.Arg231His
missense
Exon 6 of 11ENSP00000262948.4
MAP2K2
ENST00000945862.1
c.692G>Ap.Arg231His
missense
Exon 6 of 11ENSP00000615921.1
MAP2K2
ENST00000897166.1
c.692G>Ap.Arg231His
missense
Exon 6 of 11ENSP00000567225.1

Frequencies

GnomAD3 genomes
AF:
0.0000263
AC:
4
AN:
151852
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000174
AC:
3
AN:
172818
AF XY:
0.0000109
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000771
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000805
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000355
AC:
50
AN:
1409508
Hom.:
0
Cov.:
30
AF XY:
0.0000273
AC XY:
19
AN XY:
696448
show subpopulations
African (AFR)
AF:
0.0000313
AC:
1
AN:
31990
American (AMR)
AF:
0.0000815
AC:
3
AN:
36804
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25310
East Asian (EAS)
AF:
0.0000274
AC:
1
AN:
36528
South Asian (SAS)
AF:
0.0000249
AC:
2
AN:
80210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50064
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4516
European-Non Finnish (NFE)
AF:
0.0000378
AC:
41
AN:
1085626
Other (OTH)
AF:
0.0000342
AC:
2
AN:
58460
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000263
AC:
4
AN:
151852
Hom.:
0
Cov.:
31
AF XY:
0.0000405
AC XY:
3
AN XY:
74152
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41334
American (AMR)
AF:
0.0000656
AC:
1
AN:
15240
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5172
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
67940
Other (OTH)
AF:
0.00
AC:
0
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00000565
Hom.:
0
Bravo
AF:
0.0000491
ExAC
AF:
0.0000252
AC:
3
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
1
-
Cardiofaciocutaneous syndrome 4 (1)
-
1
-
MAP2K2-related disorder (1)
-
1
-
Noonan syndrome and Noonan-related syndrome (1)
-
1
-
RASopathy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.99
BayesDel_addAF
Pathogenic
0.25
D
BayesDel_noAF
Pathogenic
0.32
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.40
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.34
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.97
D
M_CAP
Pathogenic
0.59
D
MetaRNN
Pathogenic
0.88
D
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Benign
1.7
L
PhyloP100
7.9
PrimateAI
Pathogenic
0.88
D
PROVEAN
Pathogenic
-4.7
D
REVEL
Pathogenic
0.80
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.027
D
Polyphen
1.0
D
Vest4
0.86
MutPred
0.57
Loss of methylation at R231 (P = 0.0329)
MVP
0.92
MPC
1.5
ClinPred
0.88
D
GERP RS
4.2
PromoterAI
0.050
Neutral
Varity_R
0.76
gMVP
0.70
Mutation Taster
=19/81
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs730880511; hg19: chr19-4101030; COSMIC: COSV53566038; API